Quest Diagnostics names Benjamin Beauvalot VP, Chief Strategy and M&A Officer

Quest Diagnostics (DGX) announced that Benjamin Beauvalot has joined the company as SVP, Chief Strategy and M&A Officer. Prior to joining Quest, Beauvalot held leadership positions in strategy and M&A with Danaher Corporation, including VP and head of business development and strategy for Danaher’s biotechnology and genomics business areas. Beauvalot also served as vice president of strategy and corporate development and vice president of global business operations for Patheon. He was also vice president of strategy for Banner Life Sciences. Beauvalot succeeds Dermot Shorten, who is retiring in Q2 after having held the role since 2008.